Home / General / US FDA Requests Removal of Suicide Warnings From Weight-Loss Drugs

US FDA Requests Removal of Suicide Warnings From Weight-Loss Drugs

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

Jan 13 (Reuters) – The U.S. health ‌regulator ​on Tuesday asked ‌drugmakers to remove label warnings about a ​potential risk of suicidal thoughts from widely used GLP-1 ‍weight-loss drugs, including Novo Nordisk’s ​Wegovy and Eli Lilly’s Zepbound.
Th… [1213 chars]

Source: U.S. News & World Report | Published: 2026-01-13T14:57:00Z

Credit: U.S. News & World Report

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *